EUVIMEDEUVIMED entdecken
Open Access

MTUS2-AS1 suppression promotes DDX5 protein degradation to enhance the sensitivity of PARP inhibitors in BRCA-wild triple negative breast cancer

Tao Xu, Junjie Nie, Bei Pan, Qiwei Hong, Yujing Fan, Lei Dong, Jian Qin, Huiling Sun, Mu Xu, Yuqin Pan, Shukui Wang

International Journal of Biological Sciences · 20.07.2026 · 22 (12) · 6735-6751

DOI: 10.7150/ijbs.133410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 20.07.2026. Verfasst von Tao Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, DEAD-box RNA Helicases, RNA, Long Noncoding. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsPoly(ADP-ribose) Polymerase InhibitorsDEAD-box RNA HelicasesRNA, Long NoncodingHumansFemaleCell Line, TumorAnimalsDNA DamageMice

Stichwörter der Autor:innen

DDX5DNA damagePARP inhibitorlong non-coding RNAtriple-negative breast cancer

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsDEAD-box RNA HelicasesRNA, Long Noncoding

Autor:innen und Institutionen

  • General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, China.
  • Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, China.
  • Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210006, Jiangsu, China.
  • Department of Laboratory Medicine, Ganyu District People's Hospital, Kangda College of Nanjing Medical University, Lianyungang 222100, Jiangsu, China.
  • Jiangsu Cancer Personalized Medicine Collaborative Innovation Center, Nanjing 211112, Jiangsu, China.
  • Nanjing Medical Key Laboratory of Laboratory Diagnostics, Nanjing 211112, Jiangsu, China.

Zitieren

APA

Xu, T., Nie, J., Pan, B., Hong, Q., Fan, Y., Dong, L., Qin, J., Sun, H., Xu, M., Pan, Y., & Wang, S. (2026). MTUS2-AS1 suppression promotes DDX5 protein degradation to enhance the sensitivity of PARP inhibitors in BRCA-wild triple negative breast cancer. International Journal of Biological Sciences, 22(12), 6735-6751. https://doi.org/10.7150/ijbs.133410

Vancouver

Xu T, Nie J, Pan B, Hong Q, Fan Y, Dong L, et al. MTUS2-AS1 suppression promotes DDX5 protein degradation to enhance the sensitivity of PARP inhibitors in BRCA-wild triple negative breast cancer. International Journal of Biological Sciences. 2026;22(12):6735-6751. doi:10.7150/ijbs.133410

BibTeX
@article{Xu2026,
  author = {Xu, Tao and Nie, Junjie and Pan, Bei and Hong, Qiwei and Fan, Yujing and Dong, Lei and Qin, Jian and Sun, Huiling and Xu, Mu and Pan, Yuqin and Wang, Shukui},
  title = {MTUS2-AS1 suppression promotes DDX5 protein degradation to enhance the sensitivity of PARP inhibitors in BRCA-wild triple negative breast cancer},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  volume = {22},
  number = {12},
  pages = {6735--6751},
  doi = {10.7150/ijbs.133410}
}
Kostenlos starten →